Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) — Cash Flow Quality Index
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a Cash Flow Quality Index of 6.28x as of September 2025. Operating cash flow of CN¥109.83 Million exceeds net income of CN¥17.49 Million, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of Shanghai Shenqi Pharmaceutical Investmen to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 600613 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1998–2025)
Year-by-year earnings quality comparison for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A. For live market cap and the full company financial profile, see Shanghai Shenqi Pharmaceutical Investmen (600613) total market value.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.25x | CN¥124.47 Million | CN¥38.24 Million | ▲ +3.5% |
| 2024 | 3.14x | CN¥207.79 Million | CN¥66.08 Million | ▼ -16.9% |
| 2023 | 3.78x | CN¥215.59 Million | CN¥57.00 Million | ▼ -43.1% |
| 2022 | 6.65x | CN¥319.23 Million | CN¥48.01 Million | ▲ +145.3% |
| 2021 | 2.71x | CN¥184.26 Million | CN¥67.96 Million | ▲ +70.3% |
| 2019 | 1.59x | CN¥128.28 Million | CN¥80.57 Million | ▲ +5.5% |
| 2018 | 1.51x | CN¥148.53 Million | CN¥98.44 Million | ▲ +169.5% |
| 2017 | 0.56x | CN¥66.99 Million | CN¥119.64 Million | ▲ +17240.5% |
| 2016 | 0.00x | CN¥570.41K | CN¥176.65 Million | ▼ -97.7% |
| 2015 | 0.14x | CN¥30.12 Million | CN¥218.27 Million | ▲ +389.6% |
| 2014 | -0.05x | CN¥-8.62 Million | CN¥180.90 Million | ▼ -107.2% |
| 2013 | 0.66x | CN¥74.75 Million | CN¥113.13 Million | ▲ +189.3% |
| 2012 | -0.74x | CN¥-11.18 Million | CN¥15.10 Million | ▼ -326.1% |
| 2011 | -0.17x | CN¥-3.33 Million | CN¥19.16 Million | ▼ -103.3% |
| 2010 | 5.30x | CN¥33.04 Million | CN¥6.24 Million | ▲ +2.5% |
| 2008 | 5.17x | CN¥25.26 Million | CN¥4.89 Million | ▲ +366.2% |
| 2007 | 1.11x | CN¥16.01 Million | CN¥14.44 Million | ▲ +165.5% |
| 2006 | -1.69x | CN¥-6.05 Million | CN¥3.57 Million | ▼ -145.1% |
| 2005 | 3.76x | CN¥32.72 Million | CN¥8.71 Million | ▲ +1131.1% |
| 2004 | 0.31x | CN¥4.96 Million | CN¥16.26 Million | ▼ -82.3% |
| 2000 | 1.73x | CN¥26.85 Million | CN¥15.56 Million | ▲ +398.4% |
| 1999 | -0.58x | CN¥-3.28 Million | CN¥5.67 Million | ▼ -103.1% |
| 1998 | 18.69x | CN¥72.67 Million | CN¥3.89 Million | — |